← Back

Shanghai Rongtai Health Tech

Shanghai Rongtai Health Technology Corporation Limited, along with its subsidiaries, researches, develops, designs, produces, and sells massage equipment under the Rongtai and Momoda brands in China and internationally. Its offerings include massage chairs and accessories, experiential massage services, ankle revive and ROVO walking devices, small massagers, shared massage services, and smart home health gadgets such as slimming machines and beauty devices, plus purchase and after-sale services. The company also engages in software and financial activities, technology promotion and application, investment and asset management, wholesale and retail trade, e-commerce and online sales, smart home consumer devices and artificial intelligence hardware, and the research, development, manufacturing, and sales of automatic coffee machines. Products are sold through distributors, direct sales, e-commerce, experience stores, ODM, shopping mall terminals, and chain stores, and are exported. Founded in 1997, the company is based in Shanghai, China.

Country
Price · split & dividend adjusted
News & notes moving 603579.CG
603579.CG▲3

Rongtai Health's 2026 interim net profit reaches 112 million yuan, up 31.48% year-on-year

Rongtai Health released its 2026 interim report, with net profit attributable to the parent company of 112 million yuan, up 31.48% from the same period last year. Total operating revenue was 991 million yuan, up 22.29% year-on-year. Net cash flow from operating activities was negative 1.63 million yuan, down 101.81% year-on-year. The latest asset-liability ratio was 28.58%, gross margin was 29.31%, return on equity was 4.07%, and diluted earnings per share was 0.56 yuan.
603579.CG ▲
Jiemian·30dRead more →
603579.CG▲

Rongtai Health's first-half 2026 net profit rises 31.48% year on year

Rongtai Health released its 2026 semi-annual report, achieving operating revenue of 991 million yuan, up 22.29% year on year. Net profit attributable to shareholders of the listed company was 112 million yuan, up 31.48% year on year. Second-quarter net profit was 42 million yuan, down 39% quarter on quarter from 70 million yuan in the first quarter.
603579.CG ▲
CLS·30dRead more →
603579.CG2

Rongtai Health Plans to Invest 250 Million Yuan in Investment Fund

Rongtai Health plans to use 250 million yuan of its own funds to jointly establish the Feike Rongtai Investment Fund Suzhou Partnership Enterprise Limited Partnership with Kane Capital and Shanghai Feike Investment Co., Ltd. The fund has a total committed capital of 500 million yuan, with Rongtai Health contributing 49.90%. This transaction constitutes a related-party transaction because Zhang Bo, a director and board secretary of the company, serves as a director at Kane Capital. The fund will focus on investing in strategic emerging sectors such as advanced manufacturing, high-end equipment, and smart hardware, prioritizing hard-tech projects that support intelligent manufacturing technology synergies and projects or enterprises in the new consumer sector.
603579.CG
财中社·75dRead more →
© 2026 MarketDXAsset